Electroretinography, also known as ERG, is a diagnostic medical procedure that records the electrical responses of the cells of the retina in response to a light stimulus. It is used to measure and quantify the function of the cells in the retina and is a useful tool in detecting and diagnosing many retinal diseases. The primary function of ERG is to detect diseases and disorders of the retina that cause a reduction or absence of electrical activity in response to a light stimulus. By recording the electrical activity of the retinal cells, physicians can gain insight into how well the retina is working and detect diseases such as retinitis pigmentosa, glaucoma, macular degeneration, and other retinal diseases. In order to produce an ERG, a light stimulus is used to cause a response from the retinal cells. This light stimulus can be generated from a light emitting diode (LED) or a photostimulator. Once the stimulus is presented and the electrical activity in the retina is measured and recorded, the response is then quantified and assessed for any abnormalities. ERGs have been used to help diagnose diseases and disorders of the retina. By measuring the electrical activity of the retinal cells, clinicians can detect changes in the retina and identify specific diseases or disorders. This type of testing is important for detecting diseases such as retinitis pigmentosa, which can cause blindness if not diagnosed and treated early. Overall, electroretinography is an important diagnostic tool that can help clinicians detect disease and disorders of the retina. It allows physicians to quantify the electrical activity in the retinal cells, enabling them to detect diseases such as retinitis pigmentosa before vision loss occurs. It is a powerful diagnostic tool that helps physicians diagnose and treat a variety of retinal conditions.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States